Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MITO | AZN | AMGN | GILD | BMY |
| Company | Stealth Biotherapeutics Corp ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.3200 | 95.30 | 328.97 | 124.31 | 56.73 |
| High | 0.3300 | 95.36 | 329.30 | 124.57 | 57.00 |
| Low | 0.3200 | 93.41 | 325.19 | 123.12 | 55.34 |
| Latest | 0.3200 | 93.96 | 328.95 | 123.55 | 55.89 |
| Change | -0.0044 | -2.38 | -0.02 | -0.52 | -1.13 |
| % Change | -1.36% | -2.47% | -0.01% | -0.42% | -1.98% |
| Volume | 1,299,700 | 2,778,113 | 328,949 | 986,454 | 3,439,515 |
| 20-Day Average Volume | 326,330 | 5,056,895 | 2,556,040 | 5,977,673 | 13,935,278 |
| Previous Close | 0.3244 | 96.34 | 328.97 | 124.07 | 57.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3198 | 92.89 | 328.71 | 122.84 | 54.77 |
| 20-Day Raw Stochastic | 43.50% | 62.32% | 30.77% | 61.56% | 72.09% |
| 20-Day Relative Strength | 54.62 | 56.41 | 49.83 | 51.71 | 61.10 |
| Weighted Alpha | -24.32 | +43.33 | +19.75 | +29.97 | +7.67 |
| Today's Opinion | 40% Buy | 100% Buy | 48% Buy | 72% Buy | 96% Buy |
| Previous Opinion | 40% Buy | 100% Buy | 64% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 8% Sell | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.65% since 11/08/22 | -0.14% since 01/08/26 | -1.29% since 01/08/26 | +2.23% since 01/08/26 | -0.45% since 01/08/26 |
| Low | 0.3200 on 11/15/22 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 55.33 on 01/15/26 |
| High | 0.3300 on 11/15/22 | 96.43 on 01/14/26 | 332.08 on 01/09/26 | 124.52 on 01/15/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | +1.59% since 10/14/22 | +2.53% since 12/15/25 | +0.17% since 12/15/25 | +2.99% since 12/15/25 | +2.51% since 12/15/25 |
| Low | 0.3100 on 10/17/22 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.3300 on 11/15/22 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | +2.89% since 08/15/22 | +10.67% since 10/15/25 | +9.60% since 10/15/25 | +4.28% since 10/15/25 | +27.61% since 10/15/25 |
| Low | 0.2911 on 08/16/22 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.3300 on 11/15/22 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | +41.72% since 05/13/22 | +33.50% since 07/15/25 | +11.40% since 07/15/25 | +13.11% since 07/15/25 | +19.86% since 07/15/25 |
| Low | 0.1621 on 05/25/22 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 0.4270 on 06/08/22 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,537 | 298,793,856 | 177,144,096 | 153,931,168 | 116,078,640 |
| Shares Outstanding, K | 73,552 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -52,530,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -8,136,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.46 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 05/18/22 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 11/17/22 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.68 | 14.83 | 14.87 | 8.52 |